226 related articles for article (PubMed ID: 23412601)
1. 18F-Fluoride PET/CT allows detection of hyperostosis and osseous involvement in meningioma: initial experience.
Tateishi U; Tateishi K; Shizukuishi K; Shishikura A; Murata H; Inoue T; Kawahara N
Clin Nucl Med; 2013 Mar; 38(3):e125-31. PubMed ID: 23412601
[TBL] [Abstract][Full Text] [Related]
2. Multimodal approach to detect osseous involvement in meningioma: additional value of (18)F-fluoride PET/CT for conventional imaging.
Tateishi U; Tateishi K; Hino-Shishikura A; Torii I; Inoue T; Kawahara N
Radiology; 2014 Nov; 273(2):521-8. PubMed ID: 25061831
[TBL] [Abstract][Full Text] [Related]
3. 18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study.
Sharma P; Karunanithi S; Chakraborty PS; Kumar R; Seth A; Julka PK; Bal C; Kumar R
Nucl Med Commun; 2014 Dec; 35(12):1247-53. PubMed ID: 25171438
[TBL] [Abstract][Full Text] [Related]
4. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography.
Even-Sapir E; Mishani E; Flusser G; Metser U
Semin Nucl Med; 2007 Nov; 37(6):462-9. PubMed ID: 17920353
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
6. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
[TBL] [Abstract][Full Text] [Related]
7. 18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.
Avery R; Kuo PH
Clin Nucl Med; 2013 Sep; 38(9):746-8. PubMed ID: 23797230
[TBL] [Abstract][Full Text] [Related]
8. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
[TBL] [Abstract][Full Text] [Related]
9. Performance of 18F-fluoride PET or PET/CT for the detection of bone metastases: a meta-analysis.
Shen CT; Qiu ZL; Han TT; Luo QY
Clin Nucl Med; 2015 Feb; 40(2):103-10. PubMed ID: 25290289
[TBL] [Abstract][Full Text] [Related]
10. Utility of 18F-fluoride PET/CT and 18F-FDG PET/CT in the detection of bony metastases in heightened-risk head and neck cancer patients.
Chan SC; Wang HM; Ng SH; Hsu CL; Lin YJ; Lin CY; Liao CT; Yen TC
J Nucl Med; 2012 Nov; 53(11):1730-5. PubMed ID: 22961077
[TBL] [Abstract][Full Text] [Related]
11. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
[TBL] [Abstract][Full Text] [Related]
12. 18F-fluoride PET/CT scan for quantification of bone metabolism in the inner ear in patients with otosclerosis--a pilot study.
Waterval JJ; Vallinga M; Brans B; Winkens B; Stokroos RJ
Clin Nucl Med; 2013 Sep; 38(9):677-85. PubMed ID: 23816941
[TBL] [Abstract][Full Text] [Related]
13. Role of fluorine-18 fluoride PET-CT scan in the assessment of unilateral condylar hyperplasia in faciomandibular asymmetry patients: a preliminary study.
Ahmed R; Singh SP; Mittal BR; Rattan V; Parghane R; Utreja A
Nucl Med Commun; 2016 Mar; 37(3):263-72. PubMed ID: 26599065
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
[TBL] [Abstract][Full Text] [Related]
15. A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer.
Wondergem M; van der Zant FM; van der Ploeg T; Knol RJ
Nucl Med Commun; 2013 Oct; 34(10):935-45. PubMed ID: 23903557
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of (18)F-Fluoride positron emission tomography for assessment of metastatic bone tumor.
Tateishi U; Morita S; Taguri M; Shizukuishi K; Minamimoto R; Kawaguchi M; Murano T; Terauchi T; Inoue T; Kim EE
Ann Nucl Med; 2010 Aug; 24(7):523-31. PubMed ID: 20559896
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the value of dual tracer PET/CT in evaluating breast cancer.
Tateishi U; Terauchi T; Akashi-Tanaka S; Kinoshita T; Kano D; Daisaki H; Murano T; Tsuda H; Macapinlac HA
Cancer Sci; 2012 Sep; 103(9):1701-7. PubMed ID: 22632272
[TBL] [Abstract][Full Text] [Related]
18. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
[TBL] [Abstract][Full Text] [Related]
19. Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients.
Rakheja R; Makis W; Skamene S; Nahal A; Brimo F; Azoulay L; Assayag J; Turcotte R; Hickeson M
AJR Am J Roentgenol; 2012 Jun; 198(6):1409-16. PubMed ID: 22623556
[TBL] [Abstract][Full Text] [Related]
20. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
